Switch to:
More From Other Websites
Acthar's Future Could Be An Adverse Event For Mallinckrodt Jul 17 2014
Are Questcor Shareholders Getting A Good Deal? Jul 15 2014
Dumb Investment Of The Week: Mallinckrodt Plc Jul 15 2014
Update-Moody's assigns Ba2 to Mallinckrodt's new sr. secured term loan Jul 15 2014
Questcor rises after S-4 effective, interest from other suitors disclosed Jul 14 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction Jul 14 2014
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction Jul 14 2014
Questcor Discloses Side Effect Data for its Achtar Drug for the First Time Jul 11 2014
Questcor Comes Clean On Acthar; NY Times Seems To Confirm FDA Interest Jul 11 2014
Questcor reports Acthar adverse effects data, NY Times says Jul 11 2014
Questcor Reveals Adverse Events Data for Acthar for First Time Jul 10 2014
Questcor's Acthar: Refuting A Long's Optimism With Irrefutable Facts Jul 10 2014
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 10 2014
Questcor's Acthar Gel: Clinical Usage Suggests Efficacy Jul 10 2014
Questcor Pharmaceuticals (QCOR) Hits New Lifetime High Today Jul 07 2014
What Stocks Top Funds Are Buying Now Jul 02 2014
Questcor And Mallinckrodt: The Good, The Bad, And The Ugly Jun 30 2014
Hey Mallinckrodt, Pay Close Attention - UnitedHealth Just Slammed Questcor's Acthar Jun 30 2014
The FDA Owes Us An Answer On Questcor's Acthar Jun 25 2014


Add Notes, Comments or Ask Questions

User Comments

Cgrain@google
ReplyCgrain@google - 6 months ago
QCOR has legal issues that need to be resolved.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide